Nothing Special   »   [go: up one dir, main page]

LU90483B1 - Compositions nouvelles de m-thanesulfonate de parox-tine - Google Patents

Compositions nouvelles de m-thanesulfonate de parox-tine

Info

Publication number
LU90483B1
LU90483B1 LU90483A LU90483A LU90483B1 LU 90483 B1 LU90483 B1 LU 90483B1 LU 90483 A LU90483 A LU 90483A LU 90483 A LU90483 A LU 90483A LU 90483 B1 LU90483 B1 LU 90483B1
Authority
LU
Luxembourg
Prior art keywords
parox
thanesulfonate
tine
new compositions
compositions
Prior art date
Application number
LU90483A
Other languages
English (en)
Inventor
Philip Elder Dr David
Ahmad Khalaf Al Deeb A Ghazawi
Meneaud Padma Patel
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9914601.1A external-priority patent/GB9914601D0/en
Priority claimed from GBGB9914709.2A external-priority patent/GB9914709D0/en
Priority claimed from GBGB9927501.8A external-priority patent/GB9927501D0/en
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Application granted granted Critical
Publication of LU90483B1 publication Critical patent/LU90483B1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
LU90483A 1999-06-22 1999-12-03 Compositions nouvelles de m-thanesulfonate de parox-tine LU90483B1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9914601.1A GB9914601D0 (en) 1999-06-22 1999-06-22 Composition
GBGB9914709.2A GB9914709D0 (en) 1999-06-23 1999-06-23 Composition
GBGB9927501.8A GB9927501D0 (en) 1999-11-19 1999-11-19 Composition

Publications (1)

Publication Number Publication Date
LU90483B1 true LU90483B1 (fr) 2001-01-31

Family

ID=27269749

Family Applications (1)

Application Number Title Priority Date Filing Date
LU90483A LU90483B1 (fr) 1999-06-22 1999-12-03 Compositions nouvelles de m-thanesulfonate de parox-tine

Country Status (21)

Country Link
EP (1) EP1064936A1 (fr)
AT (1) AT3722U1 (fr)
AU (2) AU727000B3 (fr)
BE (2) BE1013166A6 (fr)
CA (1) CA2291542A1 (fr)
CH (1) CH690024A5 (fr)
DE (2) DE29921300U1 (fr)
DK (2) DK199900435U3 (fr)
ES (1) ES2159260B1 (fr)
FI (2) FI4488U1 (fr)
FR (1) FR2795327A1 (fr)
GB (1) GB2351233A (fr)
GR (1) GR1003490B (fr)
IE (2) IE991107A1 (fr)
IT (1) ITMI992549A1 (fr)
LU (1) LU90483B1 (fr)
NL (2) NL1013750C1 (fr)
NO (1) NO995945L (fr)
PT (1) PT102384A (fr)
SE (1) SE9904404L (fr)
WO (1) WO2000078291A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
GB0003232D0 (en) * 2000-02-11 2000-04-05 Smithkline Beecham Plc Novel composition
EP1313474A2 (fr) * 2000-08-28 2003-05-28 Synthon B.V. Compositions a base de paroxetine et leurs procedes de fabrication
EP1370515A2 (fr) 2000-08-29 2003-12-17 Ranbaxy Laboratories, Ltd. Synthese du n,n-dimethyl-3-(4-methyl)benzoyl-propionamide, un intermediaire cle du zolpidem
DE20100529U1 (de) * 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
CA2361882A1 (fr) * 2001-10-19 2003-04-19 Bernard Charles Sherman Liquide pour administration orale contenant de la paroxetine
CA2474835A1 (fr) 2002-02-01 2003-08-07 Pfizer Products Inc. Formes posologiques a liberation immediate, contenant des dispersions medicamenteuses solides
WO2005010002A1 (fr) * 2003-07-31 2005-02-03 Ranbaxy Laboratories Limited Procede pour la synthese de zolpidem
US20080033050A1 (en) * 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
CN105963273A (zh) * 2016-05-02 2016-09-28 杭州富阳伟文环保科技有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0558679A1 (fr) * 1990-11-24 1993-09-08 BEECHAM GROUP plc Utilisation de paroxetine pour le traitement de la demence senile, la boulimie, la migraine ou l'anorexie
GB9514842D0 (en) * 1995-07-20 1995-09-20 Smithkline Beecham Plc Novel formulation
GB9605828D0 (en) * 1996-03-20 1996-05-22 Smithkline Beecham Plc Treatment method
AU3108097A (en) * 1997-06-10 1998-12-30 Synthon B.V. 4-phenylpiperidine compounds
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.

Also Published As

Publication number Publication date
AU727000B3 (en) 2000-11-30
GR1003490B (el) 2000-11-30
IES991108A2 (en) 2001-04-04
BE1013166A6 (fr) 2001-10-02
GB2351233A (en) 2000-12-27
BE1012806A3 (fr) 2001-03-06
DE19958228A1 (de) 2000-12-28
FR2795327A1 (fr) 2000-12-29
CA2291542A1 (fr) 2000-12-22
NO995945L (no) 2000-12-27
FIU990494U0 (fi) 1999-12-03
IE991107A1 (en) 2001-05-30
DE29921300U1 (de) 2000-02-10
AT3722U1 (de) 2000-07-25
ES2159260B1 (es) 2002-05-01
ITMI992549A1 (it) 2001-06-03
CH690024A5 (fr) 2000-03-31
SE9904404D0 (sv) 1999-12-03
NL1013749C2 (nl) 2001-01-08
DK199900435U3 (da) 2000-02-11
ES2159260A1 (es) 2001-09-16
ITMI992549A0 (it) 1999-12-03
WO2000078291A1 (fr) 2000-12-28
PT102384A (pt) 2000-12-29
SE9904404L (sv) 2000-12-23
GB9928673D0 (en) 2000-02-02
EP1064936A1 (fr) 2001-01-03
NO995945D0 (no) 1999-12-03
FI4488U1 (fi) 2000-07-20
DK199901730A (da) 2000-12-23
NL1013750C1 (nl) 2000-12-28
AU1573100A (en) 2001-01-09
FI19992609A (fi) 2000-12-22

Similar Documents

Publication Publication Date Title
DE60000944D1 (de) Bohrlochzementzusammensetzungen
AR023440A1 (es) Composiciones antitranspirantes
NO20021116D0 (no) Ny sammensetning
IS6120A (is) Lyfjablanda
DE60031024D1 (de) Fluorkautschukzusammensetzungen
DE60028268D1 (de) Fluorkautschukzusammensetzungen
FI991485A (fi) Uusi farmaseuttinen koostumus
EA199900373A3 (ru) Фармацевтические композиции
EE200100414A (et) Valdekoksiibi kompositsioonid
PT1242087E (pt) Composicoes farmaceuticas
ITMI991754A0 (it) Composizioni cosmetiche
NO20021115L (no) Ny sammensetning
ID29785A (id) Komposisi-komposisi sampo
PT1250321E (pt) Composicao de gliburida
DE60007731D1 (de) Schweisshemmende zusammensetzungen
DE69943245D1 (de) Gaserzeugende zusammensetzung
ID30226A (id) Komposisi penat rambut
PT1239832E (pt) Composicoes farmaceuticas
DE60020341D1 (de) Kerzenzusammensetzung
LU90483B1 (fr) Compositions nouvelles de m-thanesulfonate de parox-tine
DE60008839D1 (de) Duftstoff-Zusammensetzung
DE60020682D1 (de) Resorcinenthaltende zusammensetzung
PT1051156E (pt) Composicoes farmaceuticas
ID27329A (id) Komposisi penghambat
ID30381A (id) Penggunaan arilalkanoilpiridazina